Cationic liposomes for gene delivery. 2005

Sérgio Simões, and Ana Filipe, and Henrique Faneca, and Miguel Mano, and Nuno Penacho, and Nejat Düzgünes, and Maria Pedroso de Lima
University of Coimbra, Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, Portugal. ssimoes@ci.uc.pt

Cationic liposome-DNA complexes (lipoplexes) constitute a potentially viable alternative to viral vectors for the delivery of therapeutic genes. This review will focus on various parameters governing lipoplex biological activity, from their mode of formation to in vivo behaviour. Particular emphasis is given to the mechanism of interaction of lipoplexes with cells, in an attempt to dissect the different barriers that need to be surpassed for efficient gene expression to occur. Aspects related to new trends in the formulation of lipid-based gene delivery systems aiming at overcoming some of their limitations will be covered. Finally, examples illustrating the potential of cationic liposomes in clinical applications will be provided.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009685 Nuclear Envelope The membrane system of the CELL NUCLEUS that surrounds the nucleoplasm. It consists of two concentric membranes separated by the perinuclear space. The structures of the envelope where it opens to the cytoplasm are called the nuclear pores (NUCLEAR PORE). Nuclear Membrane,Envelope, Nuclear,Envelopes, Nuclear,Membrane, Nuclear,Membranes, Nuclear,Nuclear Envelopes,Nuclear Membranes
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D002412 Cations Positively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis. Cation
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA

Related Publications

Sérgio Simões, and Ana Filipe, and Henrique Faneca, and Miguel Mano, and Nuno Penacho, and Nejat Düzgünes, and Maria Pedroso de Lima
March 1998, Nihon rinsho. Japanese journal of clinical medicine,
Sérgio Simões, and Ana Filipe, and Henrique Faneca, and Miguel Mano, and Nuno Penacho, and Nejat Düzgünes, and Maria Pedroso de Lima
October 2014, Colloids and surfaces. B, Biointerfaces,
Sérgio Simões, and Ana Filipe, and Henrique Faneca, and Miguel Mano, and Nuno Penacho, and Nejat Düzgünes, and Maria Pedroso de Lima
January 2002, Critical reviews in therapeutic drug carrier systems,
Sérgio Simões, and Ana Filipe, and Henrique Faneca, and Miguel Mano, and Nuno Penacho, and Nejat Düzgünes, and Maria Pedroso de Lima
July 2003, Current medicinal chemistry,
Sérgio Simões, and Ana Filipe, and Henrique Faneca, and Miguel Mano, and Nuno Penacho, and Nejat Düzgünes, and Maria Pedroso de Lima
September 2010, International journal of pharmaceutics,
Sérgio Simões, and Ana Filipe, and Henrique Faneca, and Miguel Mano, and Nuno Penacho, and Nejat Düzgünes, and Maria Pedroso de Lima
August 2003, Journal of drug targeting,
Sérgio Simões, and Ana Filipe, and Henrique Faneca, and Miguel Mano, and Nuno Penacho, and Nejat Düzgünes, and Maria Pedroso de Lima
June 2020, Biomaterials science,
Sérgio Simões, and Ana Filipe, and Henrique Faneca, and Miguel Mano, and Nuno Penacho, and Nejat Düzgünes, and Maria Pedroso de Lima
November 2002, Pharmaceutical research,
Sérgio Simões, and Ana Filipe, and Henrique Faneca, and Miguel Mano, and Nuno Penacho, and Nejat Düzgünes, and Maria Pedroso de Lima
September 2016, Colloids and surfaces. B, Biointerfaces,
Sérgio Simões, and Ana Filipe, and Henrique Faneca, and Miguel Mano, and Nuno Penacho, and Nejat Düzgünes, and Maria Pedroso de Lima
January 2021, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!